课题基金 / 基金详情

项目摘要

项目成果

Kelly A Foster的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):长时程增强(LTP)和长时程抑制(LTD)是突触强度的持久、活动依赖性变化,已被提出为学习和记忆的基础。这些形式的可塑性依赖于NMDA受体的激活,最近的研究表明,这些NMDA受体的亚基组成(特别是受体复合物是否包含NR2A与NR2B亚基)起着重要的作用,无论是他们的激活导致LTP或LTD。然而,这些研究主要是药理学,提供了相互矛盾的结果,他们的结论仍然有些争议。该建议的第一个目的是使用药理学拮抗剂来确定NR2A和NR2B在长期可塑性中的作用是否随发育而改变。第二个目的是研究这些亚基除了作为受体通道的作用外,还作为分子支架的作用。这将通过评估使用RNAi降低NR2A和NR2B表达对LTP和LTD的影响来完成。第三个目的是增加NR2A在光剥夺大鼠视皮层的表达,以研究NR2A在经验依赖性可塑性中的作用。
英文摘要
DESCRIPTION (provided by applicant): Long-term potentiation (LTP) and long-term depression (LTD) are lasting, activity-dependent changes in synaptic strength that have been proposed to underlie learning and memory. These forms of plasticity are dependent on NMDA receptor activation, and recent studies have suggested that the subunit composition of these NMDA receptors (specifically whether the receptor complex contains the NR2A versus the NR2B subunit) plays an important role in whether their activation leads to LTP or LTD. However, these studies are primarily pharmacological, have provided conflicting results, and their conclusions remain somewhat controversial. The first aim of this proposal is to use pharmacological antagonists to determine whether the roles of the NR2A and NR2B in long-term plasticity change over development. The second aim is to investigate the roles of these subunits as molecular scaffolds in addition to their roles as receptor-channels. This will be done by evaluating the impact on LTP and LTD of decreasing NR2A and NR2B expression using RNAi. The third aim is to increase NR2A expression in the visual cortex of light-deprived rats to study the role of NR2A in experience-dependent plasticity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Roles of NR2A and NR2B in Excitotoxicity
The Roles of NR2A and NR2B in Long-Term Plasticity
The Roles of NR2A and NR2B in Long-Term Plasticity
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: